Rensat Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2020)
- Net Worth -5.00%
(FY 2020)
- Total Assets %
(FY 2020)
About Rensat Pharma
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Maheshbhai Dalpatbhai, Jainish Bharatbhai, Alihusain Maknojiya, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51909GJ2018PTC101735
- Company No.
101735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Banaskantha, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rensat Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maheshbhai Dalpatbhai  | Director | 10-Apr-2018 | Current |
| Jainish Bharatbhai | Director | 10-Apr-2018 | Current |
| Alihusain Maknojiya | Director | 02-Jul-2018 | Current |
| Ramilaben Chaudhari | Director | 02-Jul-2018 | Current |
| Sonal Dave | Director | 02-Jul-2018 | Current |
Financial Performance of Rensat Pharma.
Rensat Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rensat Pharma?
Unlock access to Rensat Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Akshar Pathology Laboratory Private LimitedActive 1 year 4 months
Ramilaben Chaudhari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rensat Pharma?
Unlock and access historical data on people associated with Rensat Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rensat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rensat Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
